BioCryst Pharmaceuticals Inc at Jefferies Healthcare Conference Transcript
Hi, everyone. My name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies. I'm happy to introduce our guests today, Jon Stonehouse, the President and CEO of BioCryst and also John Bluth is with us as well. We're going to do fireside chat format. Thanks for joining us today.
Questions & Answers
And maybe to start off, if Jon, you want to give a one minute intro to BioCryst?
Sure. Thanks, Maury, for inviting us in -- inviting us to your healthcare conference. So we're a company that develops -- discovers and develops, and commercializes small molecules for patients suffering from rare disease to give them the opportunity to have an oral drug. And it's a big deal for patients. It's not some incremental convenience improvement if they can take a once-a-day capsule. It has the effect of being like a daily vitamin and they forget their sex. They're
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
